Rampart Bioscience

Rampart Bioscience is pioneering new approaches to liberate patients and families from the burden of severe, debilitating diseases. Rampart's multidisciplinary team is developing novel DNA-based medicines with potency and durability that can deliver transformative, long-lasting clinical benefits. The company is initially focused on genetic disorders affecting the liver, with its first program aimed at treating a rare hereditary condition—hypophosphatasia.